Numinus Wellness Founders to Resume Original Executive Roles
A cease trade order remains in effect as management pursues its revocation and a conditional Canadian Securities Exchange listing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Numinus Wellness (NUMIF) announced that its founders will resume their original executive leadership roles, effective October 1, 2026. Payton Nyquvest returns as Chief Executive Officer while continuing as Board Chair, a combined role he previously held. Co-founder Michael Tan returns as Chief Operating Officer, responsible for operational execution and product development initiatives. Both had taken transitional roles during the company's restructuring.
A cease trade order remains in effect. Management has submitted an updated application to the British Columbia Securities Commission seeking its revocation and intends to continue advancing an application to list common shares on the Canadian Securities Exchange. Management identifies these steps as its primary strategy to restore trading and enhance shareholder liquidity. The proposed listing depends on meeting the exchange's listing requirements and obtaining its approval.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointAn updated application has been submitted to the British Columbia Securities Commission seeking cease trade order revocation.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Management intends to advance a Canadian Securities Exchange listing application as part of its trading-restoration strategy.
Negative
- Major pointThe current cease trade order remains in effect.
- Minor point. Forward-looking: it has not happened yet and may not happen.The proposed Canadian Securities Exchange listing requires satisfying listing requirements and obtaining exchange approval.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Vancouver, British Columbia--(Newsfile Corp. - October 1, 2026) - Numinus Wellness Inc. (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced that its founders will resume their original executive leadership roles, effective October 1, 2026.
Payton Nyquvest, founder and Executive Chair, will return to the role of Chief Executive Officer while continuing as Board Chair, a combined role he previously held. Michael Tan, co-founder, will return to the role of Chief Operating Officer, with responsibility for operational execution and the Company's product development initiatives. Both founders stepped into transitional roles through the Company's restructuring and now return to the leadership structure under which Numinus was originally built.
"I'm grateful for Michael's leadership through Numinus' restructuring and am energized to lead Numinus into its next phase of supporting clinics to deliver these therapies as the field advances," said Mr. Nyquvest.
Management is continuing to work towards achieving revocation of the current cease trade order ("CTO") that is in effect, and to that end it has submitted an updated application with the British Columbia Securities Commission (the "BCSC"). Management also intends to continue advancing its application to list its common shares on the Canadian Securities Exchange (the "CSE"). Successfully executing these steps remains management's primary strategy to restore trading, enhance shareholder liquidity, and position the Company for its next phase of growth. A listing on the CSE will be contingent on the Company satisfying the CSE's listing requirements and being approved for the listing on that exchange.
About Numinus
Numinus Wellness Inc. (OTC Pink: NUMIF) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic research and training – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinusnetwork.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
SOURCE Numinus Wellness Inc.
For more information:
Investor Contact
Craig MacPhail
invest@numinusnetwork.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/317015
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is returning to executive leadership at Numinus Wellness, and when?
Payton Nyquvest returns as Chief Executive Officer and Michael Tan as Chief Operating Officer, effective October 1, 2026. Nyquvest continues as Board Chair. Tan is responsible for operational execution and product development initiatives.